Contact
Please use this form to send email to PR contact of this press release:
Opiant Pharmaceuticals Receives Approximately $5.3 Million of Cash from Exercise of Outstanding Warrants
TO:
Please use this form to send email to PR contact of this press release:
Opiant Pharmaceuticals Receives Approximately $5.3 Million of Cash from Exercise of Outstanding Warrants
TO: